Find a Doctor

Gerasimos S. Filippatos
GF
Areas of Expertise

Gerasimos S. Filippatos

Attikon Hospital
Cardiology
Male

Bio

Gerasimos Filippatos is a Cardiologist in Athens, Greece. He has been an author on 526 peer reviewed articles in the past 15 years.

Areas of Expertise

Contact

Athens, GR

Latest Research

Latest Advance
Study
  • Condition: Chronic Kidney Disease
  • Journal: The New England journal of medicine
  • Treatment Used: Finerenone
  • Number of Patients: 2833
  • Published —
In this study, researchers evaluated the outcomes of treating chronic kidney disease with finerenone.
Latest Advance
Study
  • Condition: Iron Deficiency
  • Journal: Lancet (London, England)
  • Treatment Used: Ferric Carboxymaltose
  • Number of Patients: 1108
  • Published —
In this study, researchers evaluated the outcomes of using ferric carboxymaltose for the treatment of iron deficiency after acute heart failure.
Latest Advance
Study
  • Condition: Heart Failure with Reduced Ejection Fraction
  • Journal: Lancet (London, England)
  • Treatment Used: Sodium-glucose Co-transporter-2 Inhibitors
  • Number of Patients: 8474
  • Published —
The study researched the outcomes of sodium-glucose co-transporter-2 inhibitors for patients with heart failure with reduced ejection fraction.
Latest Advance
Study
  • Condition: Heart Failure
  • Journal: The New England journal of medicine
  • Treatment Used: Empagliflozin
  • Number of Patients: 3730
  • Published —
This study evaluated the effectiveness of Empagliflozin treatment in patients with heart failure.
Latest Advance
Study
  • Condition: Heart Failure with Reduced Ejection Fraction
  • Journal: Journal of cardiac failure
  • Treatment Used: Elamipretide
  • Number of Patients: 71
  • Published —
This study evaluated the effects of multiple subcutaneous doses of elamipretide on left ventricular end systolic volume to treat patients with heart failure with reduced ejection fraction.
Latest Advance
Study
  • Condition: Patients with Heart Failure and Reduced Ejection Fraction (HFrEF)
  • Journal: Clinical research in cardiology : official journal of the German Cardiac Society
  • Treatment Used: Loop Diuretics
  • Number of Patients: 2338
  • Published —
This study determined whether loop diuretics might dampen uptitration of inhibitors in patients with heart failure and reduced ejection fraction (HFrEF).
Latest Advance
Study
  • Condition: Acute heart failure
  • Journal: European journal of heart failure
  • Treatment Used: Serelaxin
  • Number of Patients: 11359
  • Published —
The study researched the effects of Serelaxin for patients admitted for acute heart failure.
Latest Advance
Study
  • Condition: Acute Heart Failure
  • Journal: The New England journal of medicine
  • Treatment Used: Serelaxin
  • Number of Patients: 6545
  • Published —
The study aimed to determine the effect of Serelaxin in treating acute heart failure.
Latest Advance
Study
  • Condition: Heart Failure
  • Journal: European journal of heart failure
  • Treatment Used: Below-Target and Target Dose Enalapril
  • Number of Patients: 0
  • Published —
This study examined associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF).

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Study
  • Journal: The New England journal of medicine
  • Published —
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Publication
Study
  • Journal: European journal of heart failure
  • Published —
Arrhythmias in cancer: Rhythm is gonna get you!

Contact

Athens, GR

Insurance

Contact them to find out if they accept your insurance plan.